Zobrazeno 1 - 10
of 28
pro vyhledávání: '"José Luis Relova"'
Autor:
Gustavo Fernández-Pajarín, Ángel Sesar, José Luis Relova, Begoña Ares, Isabel Jiménez, Miguel Gelabert-González, Eduardo Arán, Alfonso Castro
Publikováno v:
Diagnostics, Vol 12, Iss 4, p 1001 (2022)
Background: The relationship between axial symptoms in Parkinson’s disease (PD) and subthalamic deep brain stimulation (STN-DBS) is still unclear. Purpose: We searched for particular clinical characteristics before STN-DBS linked to on-state axial
Externí odkaz:
https://doaj.org/article/5d7a234da12442daa2497927ff384138
Autor:
Jessica González‐Sánchez, Agustín Sánchez‐Temprano, Tania Cid‐Díaz, Regina Pabst‐Fernández, Carlos S. Mosteiro, Rosalía Gallego, Ruben Nogueiras, Xesús Casabiell, Gillian S. Butler‐Browne, Vincent Mouly, José Luis Relova, Yolanda Pazos, Jesús P. Camiña
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 9, Iss 6, Pp 1063-1078 (2018)
Abstract Background This study was performed to test the therapeutic potential of obestatin, an autocrine anabolic factor regulating skeletal muscle repair, to ameliorate the Duchenne muscular dystrophy (DMD) phenotype. Methods and results Using a mu
Externí odkaz:
https://doaj.org/article/ac85ac9944404db6b8a8d3a098d48356
Autor:
José Luis Relova, Ángel Sesar, A. Castro, Miguel Gelabert, Eduardo Arán-Echabe, Gustavo Fernández-Pajarín, Isabel Jiménez-Martín, Begoña Ares
Publikováno v:
Movement Disorders Clinical Practice
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
instname
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
instname
Background: Background Studies comparing the clinical efficacy of apomorphine infusion (APO) with subsequent subthalamic deep brain stimulation (STN-DBS) in advanced Parkinson’s disease (aPD) are currently lacking. Retrospective data have shown tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::464b6ddbebd7dad9c969679cf726d9e7
https://doi.org/10.1002/mdc3.13338
https://doi.org/10.1002/mdc3.13338
Obestatin signalling counteracts glucocorticoid‐induced skeletal muscle atrophy via NEDD4/KLF15 axis
Autor:
Vincent Mouly, José Luis Relova, Saul Leal-lopez, Jesus P. Camiña, Manuel E. Rodríguez‐Fuentes, Icía Santos-Zas, Luis J. Andrade‐Bulos, Jessica González-Sánchez, Yolanda Pazos, Carlos S. Mosteiro, Xesús Casabiell, Tania Cid-Díaz, Fátima Fernández‐Barreiro
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 12, Iss 2, Pp 493-505 (2021)
Journal of Cachexia, Sarcopenia and Muscle
Journal of Cachexia, Sarcopenia and Muscle, In press, ⟨10.1002/jcsm.12677⟩
Journal of Cachexia, Sarcopenia and Muscle, Wiley Open Access/Springer Verlag, In press, ⟨10.1002/jcsm.12677⟩
Journal of Cachexia, Sarcopenia and Muscle, Wiley Open Access/Springer Verlag, 2021, 12 (2), pp.493-505. ⟨10.1002/jcsm.12677⟩
Journal of Cachexia, Sarcopenia and Muscle
Journal of Cachexia, Sarcopenia and Muscle, In press, ⟨10.1002/jcsm.12677⟩
Journal of Cachexia, Sarcopenia and Muscle, Wiley Open Access/Springer Verlag, In press, ⟨10.1002/jcsm.12677⟩
Journal of Cachexia, Sarcopenia and Muscle, Wiley Open Access/Springer Verlag, 2021, 12 (2), pp.493-505. ⟨10.1002/jcsm.12677⟩
International audience; Background: A therapeutic approach for the treatment of glucocorticoid‐induced skeletal muscle atrophy should be based on the knowledge of the molecular mechanisms determining the unbalance between anabolic and catabolic pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb3ea29729724ef9bd54613290241f11
https://doaj.org/article/6aba5e89c5064f319ade19594e974fcf
https://doaj.org/article/6aba5e89c5064f319ade19594e974fcf
Autor:
José Luis Relova, Begoña Ares, Ángel Sesar, Eduardo Arán, Miguel Gelabert-González, A. Castro, Gustavo Fernández-Pajarín, María-Teresa Rivas
Publikováno v:
Journal of Neurology. 266:659-666
Deep brain stimulation (DBS) is an effective therapy for patients with advanced Parkinson’s disease (PD). However, sometimes, it is not sufficient to adequately control motor symptoms. We describe our experience with continuous subcutaneous apomorp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbe5839f50221750179877a02aab0dfd
https://doi.org/10.1007/s00415-019-09184-5
https://doi.org/10.1007/s00415-019-09184-5
Publikováno v:
Minerva: Repositorio Institucional de la Universidad de Santiago de Compostela
Universidad de Santiago de Compostela (USC)
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
instname
Universidad de Santiago de Compostela (USC)
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
instname
Targeting apoptosis in the ischemic penumbra is a rational therapeutic approach for restricting cerebral infarct volume after clinical stroke. The present work explored the capability of the obestatin peptide, as a novel approach to inhibit apoptotic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93fd8987ea87eeb0c81ab49bc6255e2c
https://pubmed.ncbi.nlm.nih.gov/33400083
https://pubmed.ncbi.nlm.nih.gov/33400083
Autor:
José Luis Relova, Xesús Casabiell, Jesus P. Camiña, Carlos S. Mosteiro, Jessica González-Sánchez, Gillian Butler-Browne, Yolanda Pazos, Rosalía Gallego, Tania Cid-Díaz, Rubén Nogueiras, Agustin Sanchez-Temprano, Vincent Mouly, Regina Pabst‐Fernández
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle. 9:1063-1078
BACKGROUND This study was performed to test the therapeutic potential of obestatin, an autocrine anabolic factor regulating skeletal muscle repair, to ameliorate the Duchenne muscular dystrophy (DMD) phenotype. METHODS AND RESULTS Using a multidiscip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ea7e5408774589453e9318215455706
https://doi.org/10.1002/jcsm.12338
https://doi.org/10.1002/jcsm.12338
Autor:
Ángel Sesar, José Luis Relova, A. Castro, Miguel Gelabert-González, Begoña Ares, Gustavo Fernández-Pajarín, E Arán
Publikováno v:
Acta Neurochirurgica. 159:1713-1719
Over the years, most of the deep brain stimulation (DBS) complications described have been mainly related to the surgery itself or the stimulation. Only a few authors have dealt with chronic complications or complications due to implanted material. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28639d766d9d0bdec61d8b65c99ac1f3
https://doi.org/10.1007/s00701-017-3252-7
https://doi.org/10.1007/s00701-017-3252-7
Autor:
José Luis Relova, Miguel Gelabert-González, Ángel Sesar, Gustavo Fernández-Pajarín, A. Castro, Patricia Blanco-Arias, Begoña Ares, I. Jiménez-Martín
Publikováno v:
Acta Neurochirurgica. 158:2023-2028
Myoclonus-dystonia syndrome (MDS) is an autosomal dominant movement disorder caused by mutations in the SGCE gene. MDS is characterized by mild dystonia and myoclonic jerks, and a constellation of psychiatric manifestations. Deep brain stimulation (D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d8792b21aa01441b44b3e37e78a4a7c
https://doi.org/10.1007/s00701-016-2904-3
https://doi.org/10.1007/s00701-016-2904-3
Autor:
José Luis Relova, Tania Cid-Díaz, Carlos Seoane-Mosteiro, Uxía Gurriarán-Rodríguez, Begoña Porteiro, Rosalía Gallego, Jesus P. Camiña, Jessica González-Sánchez, Rubén Nogueiras, Xesús Casabiell, Icía Santos-Zas, Yolanda Pazos, Vincent Mouly
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-1 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-1 (2018)
Obestatin/GPR39 signaling stimulates skeletal muscle growth and repair by inducing both G-protein-dependent and -independent mechanisms linking the activated GPR39 receptor with distinct sets of accessory and effector proteins. In this work, we descr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a01b3e45c3b9626d6b6dd5d73988be5
http://europepmc.org/articles/PMC6294773
http://europepmc.org/articles/PMC6294773